Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
A reverse discounted cash flow is not shown for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Classified from the filings: SIC code.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Allbaugh Larry Eugene Director | Giftindirect | 50,000 | $0.00 | $0 |
| 2026-07-22 | 2 co-filers Group filing | Open-market buyindirect | 5,682 | $44.00 | $250k |
| 2026-07-22 | Perry-Smith Robert Truxtun Director | Open-market buyindirect | 31,363 | $44.00 | $1.4m |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 2026-07-22 | Lucas Donna Director | Open-market buyindirect | 1,136 | $44.00 | $50k |
| 2026-07-22 | Riggs Judson Teichert Director | Open-market buyindirect | 2,273 | $44.00 | $100k |
| 2026-07-22 | Ramos Kevin Francis Director | Open-market buyindirect | 5,682 | $44.00 | $250k |
| 2026-07-22 | 2 co-filers Group filing | Open-market buyindirect | 5,682 | $44.00 | $250k |
| 2026-07-22 | 2 co-filers Group filing | Open-market buyindirect | 90,909 | $44.00 | $4.0m |
| 2026-05-29 | Allbaugh Larry Eugene Director | Giftindirect | 150,000 | $0.00 | $0 |
| 2026-05-26 | Wait Brett Levi SVP, Chief Information Officer | Open-market sale | 1,640 | $42.27 | $69k |
| 2026-05-21 | Wetton Shelley Ronan SVP, Chief Marketing Officer | Grant | 905 | $0.00 | $0 |
| 2026-05-21 | Wait Brett Levi SVP, Chief Information Officer | Grant | 905 | $0.00 | $0 |
| 2026-05-21 | Rizzo Michael Anthony EVP, Chief Banking Officer | Grantindirect | 2,715 | $0.00 | $0 |
| 2026-05-21 | Ramirez-Medina Lydia Ann EVP, Chief Operating Officer | Grant | 2,715 | $0.00 | $0 |
| 2026-05-21 | Luck Heather Christina EVP, Chief Financial Officer | Grant | 2,715 | $0.00 | $0 |
| 2026-05-21 | 2 co-filers SVP, Chief Regulatory Officer | Open-market saleindirect | 867 | $41.23 | $36k |
| 2026-05-21 | Kurtze Don Justin EVP, SF Bay Area President | Grant | 2,715 | $0.00 | $0 |
| 2026-05-21 | Dalton John William SVP, Chief Credit Officer | Grant | 905 | $0.00 | $0 |
| 2026-05-21 | 2 co-filers SVP, Chief Regulatory Officer | Grantindirect | 905 | $0.00 | $0 |
| 2026-05-20 | 3 co-filers President & CEO | Open-market saleindirect | 2,000 | $41.12 | $82k |
| 2026-05-20 | 3 co-filers President & CEO | Open-market saleindirect | 2,000 | $41.22 | $82k |
| 2026-05-20 | 3 co-filers President & CEO | Open-market saleindirect | 2,428 | $41.34 | $100k |
| 2026-05-14 | Wait Brett Levi SVP & CIO | Open-market sale | 2,583 | $41.11 | $106k |
| 2026-05-07 | Lee Michael Eugene SVP & Chief Regulatory Officer | Open-market saleindirect | 1,641 | $41.26 | $68k |
| 2026-05-06 | Ramirez-Medina Lydia Ann EVP & Chief Operating Officer | Open-market sale | 400 | $40.99 | $16k |
| 2026-03-09 | 2 co-filers President & CEO | Open-market saleindirect | 2,000 | $36.74 | $73k |
| 2026-03-09 | 2 co-filers President & CEO | Open-market saleindirect | 2,000 | $36.57 | $73k |
| 2026-02-20 | Lee Michael Eugene SVP & Chief Regulatory Officer | Open-market saleindirect | 1,200 | $39.30 | $47k |
| 2026-02-17 | Lee Michael Eugene SVP & Chief Regulatory Officer | Open-market saleindirect | 1,200 | $40.73 | $49k |
| 2026-01-29 | Allbaugh Larry Eugene Director | Grantindirect | 974 | $0.00 | $0 |
| 2026-01-29 | Deary-Bell Shannon Director | Grantindirect | 974 | $0.00 | $0 |
| 2026-01-29 | Kashiwagi Warren Paul Director | Grant | 974 | $0.00 | $0 |
| 2026-01-29 | Lucas Donna Director | Grantindirect | 974 | $0.00 | $0 |
| 2026-01-29 | Nickum David Frank Director | Grantindirect | 974 | $0.00 | $0 |
| 2026-01-29 | Perry-Smith Robert Truxtun Director | Grantindirect | 974 | $0.00 | $0 |
| 2026-01-29 | Ramos Kevin Francis Director | Grantindirect | 974 | $0.00 | $0 |
| 2026-01-29 | Reynoso Randall E Director | Grant | 974 | $0.00 | $0 |
| 2026-01-29 | Riggs Judson Teichert Director | Grantindirect | 974 | $0.00 | $0 |
| 2025-12-12 | Rizzo Michael Anthony EVP & Chief Banking Officer | Open-market saleindirect | 641 | $37.28 | $24k |
| 2025-11-19 | Ramirez-Medina Lydia Ann EVP & Chief Operating Officer | Open-market sale | 600 | $33.07 | $20k |
Top 32 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 24% of free cash flow, leaving room to grow it and fund buybacks. Last year: $17.1M dividends + $0 buybacks = $17.1M returned on $71.4M FCF.
2 consecutive years of dividend increases · -28%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 6 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 14%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 6 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Interest Expense | — | — | $63.5M | $14.8M | $4.0M | $9.2M |
| Pretax Income | $83.7M | $64.7M | $66.6M | $62.9M | $47.1M | $37.3M |
| Income Tax Expense | $22.1M | $19.1M | $18.9M | $18.1M | $4.7M | $1.3M |
| Net Income | $61.6M | $45.7M | $47.7M | $44.8M | $42.4M | $35.9M |
| Per Share | ||||||
| EPS (Basic) | $2.90 | $2.26 | $2.78 | $2.61 | $2.83 | $3.57 |
| EPS (Diluted) | $2.90 | $2.26 | $2.78 | $2.61 | $2.83 | $3.57 |
| Weighted Avg Shares (Basic) | 21.2M | 20.2M | 17.2M | 17.1M | 15.0M | 10.1M |
| Weighted Avg Shares (Diluted) | 21.3M | 20.2M | 17.2M | 17.2M | 15.0M | 10.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-30
Where each multiple sits in its own 5-yr range · 100th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 14% against ROIC 14% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on FSBC: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Leverage ratios is not shown for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Classified from the filings: SIC code.
How much the company owes, how it's trended, and how comfortably it's serviced.
Interest expense isn't separately reported — often netted into “other income (expense), net.” Interest last disclosed in FY2023 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Ranked against 19 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| STT | $46.2B | 18.1× | — | 3.3× | 7.3% | — | 21.1% | 10.6% | 10.6% | — | 388 |
| NTRS | $30.9B | 19.4× | — | 3.8× | -2.5% | — | 21.5% | 13.4% | 13.4% | — | 272 |
| CFG | $26.7B | 16.5× | — | 3.2× | 5.6% | — | 22.2% | 7.0% | 4.9% | — | 319 |
| FCNCA | $26.1B | 14.2× | — | 2.7× | -2.2% | — | 23.1% | 9.9% | 3.8% | — | 162 |
| ALLY | $11.6B | 16.1× | — | 1.5× | -3.3% | — | 10.8% | 5.5% | 2.5% | — | 140 |
| UCB | $4.4B | 14.0× | — | 4.1× | 11.7% | — | 30.9% | 9.0% | 8.5% | — | 84 |
| FBP | $4.0B | 12.2× | — | 3.1× | 2.4% | — | 27.5% | 17.5% | 15.3% | — | 67 |
| FHB | $3.1B | 11.4× | — | 3.5× | 8.9% | — | 31.4% | 10.0% | 10.0% | — | 74 |
| BUSE | $2.4B | 19.6× | — | 3.3× | 55.7% | — | 18.8% | 5.5% | 5.5% | — | 61 |
| GABC | $1.8B | 16.0× | — | 3.8× | 37.8% | — | 23.1% | 9.7% | 8.9% | — | 39 |
| PEBO | $1.4B | 12.9× | 12.8× | 16.0× | 2.3% | — | — | 8.8% | 5.8% | 3.1× | 41 |
| FSBC | $1.1B | 15.5× | — | — | — | — | — | 13.8% | 13.8% | — | 29 |
| UVSP | $1.1B | 12.7× | — | 3.3× | 9.6% | — | 27.7% | 9.6% | 9.4% | — | 49 |
| FMNB | $927M | 10.8× | — | 3.3× | 3.9% | — | 19.5% | 11.2% | 6.4% | — | 33 |
| WASH | $736M | 14.2× | — | 3.2× | 128% | — | 22.8% | 9.6% | 9.6% | — | 39 |
| ACNB | $665M | 18.2× | — | 3.5× | 45.1% | — | 19.3% | 8.8% | 5.0% | — | 22 |
| COFS | $530M | 17.6× | — | 2.3× | 63.6% | — | 12.4% | 6.1% | 6.1% | — | 23 |
| CFFI | $357M | 13.2× | — | 2.5× | 10.6% | — | 19.1% | 10.3% | 9.5% | — | 11 |
| MYFW | $303M | 23.1× | — | 3.1× | 7.6% | — | 13.6% | 5.0% | 5.0% | — | 17 |
| MNSB | $152M | 12.1× | — | 1.1× | -1.6% | 54.3% | 11.5% | 7.1% | 7.1% | — | 16 |
Peers = companies sharing FSBC's sector (State Commercial Banks) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
Return on equity (14%) and return on invested capital (14%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Converts 0.95x of reported profit into free cash flow over 5 years, with accruals negative.
Shares outstanding are up 94% since FY2020 — per-share cash flow has grown more slowly than the totals above, and the gap is the owners'.
Leverage is not measurable this way for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Missing from our data, so excluded from this answer: capital adequacy metrics for this archetype.
At $44.92, free cash flow must compound 8.09%/yr for 10 years. It has done 7.12%/yr over 5 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2021 | −44.8% | 8.1% |
| FY2022 | 62.8% | 8.1% |
| FY2023 | −15.9% | 8.1% |
| FY2024 | 33.7% | 8.1% |
| FY2025 | 39.6% | 8.1% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The cost of capital could not be computed for this company, so the requirement is solved at the published 10% default — a different rate would move it materially.
| Step | Amount | Running total |
|---|---|---|
| Net income | $62M | $62M |
| Share-based comp | $1M | $63M |
| Other non-cash & working capital | $10M | $73M |
| Operating cash flow | $73M | $73M |
| Capex | −$1M | $71M |
| Free cash flow | $71M | $71M |
| FCF after SBC | $70M | $70M |
| Fiscal year | Accruals / assets |
|---|---|
| FY2020 | -0.8 percent |
| FY2021 | 0.5 percent |
| FY2022 | -0.0 percent |
| FY2023 | 0.3 percent |
| FY2024 | -0.1 percent |
| FY2025 | -0.2 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.